Please Note: Schedule and room assignment are subject to change.
Off Label Therapy Adoption in Ophthalmology: Role, Rights and Responsibility of Eye Doctors (SOI)
Tue. 19 June 2018: 08:30
Room: Room 23
The session is dedicated to the use of Off label Therapy in Ophthalmology. The different roles, advantages and possible weak points, if compared with on label therapy, will be demonstrated and discussed. To date, in many Countries, the Eye Doctors rights to adopt off label therapy to support ophthalmological patients is controversial from the point of view of the drugs regulatory organizations. In this symposium the attendees will have the opportunity to deeply improve their knowledge on off label therapy use and on how to adopt it in the safer and more effective way to support at best ophthalmic patients needs.
1. To learn Off label Therapy Adoption in Ophthalmology
2. To learn about Responsibility of Eye Doctors in Adopting Off label Therapy
3. To learn Patients Advantages in using Off label Therapy
Italian Society of Ophthalmology
Breaf description of off label therapy during pediatric age in ophthalmology
The presenter will discuss different aspects regarding off label medical therapies in glaucoma. A particular emphasis will be given to the use of antimetabolites during and after glaucoma surgical procedures. The results of a RCT on safety and efficacy of off label hypotensive ocular therapy for congenital glaucoma will be reported.